Aprepitant in the Management of Immune Checkpoint Inhibitors Pruritus in Solid Cancer Patients
Clinical trial NCT06931119 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06931119
- Sponsor
- Rabin Medical Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-30
- Primary completion
- 2026-05-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.